Vascular reactivity

Thursday, 11 April 2002

Organizer

D. Hayoz (Lausanne, CHUV, Switzerland)
P. Silacci (Lausanne, EPFL, Switzerland)
 

Sponsors

Novartis
Astra-Zeneca
 

Vascular reactivity: mechanical stress and CV response

Session I

 
Abstract no
Chair P. Silacci (Lausanne, Switzerland)  
9.45 – 10.05 Flow environment and the endothelium
J. Shyy (Riverside, USA)
 
10.05 – 10.25 Mechanical stress and the SMC
Z. Yang (Fribourg, Switzerland)
 
10.25 – 10.45 Vascular wall stiffness in animal models
J. Atkinson (Nancy, France)
 
10.45 – 11.15 coffee break  
Chair D. Hayoz (Lausanne, Switzerland)  
11.15 – 11.35 Diagnostic tools to assess vascular function in humans
D. Duprez (Gent, Belgium)
 
11.35 – 11.55 Cardiovascular risk factors and large artery response
J. Blacher (Paris, France)
 
11.55 – 12.15 Arterial stiffness and drug treatment
L.van Bortel (Gent, Belgium)
 
12.15 – 12.30 Myocardial regeneration with bone marrow cells
M.Brehm, T. Zeus, M. Köstering, G. Kögler, P. Wernet, and B.E. Strauer (Düsseldorf, Germany)
76
12.30 end of workshop 5  
             

Workshop 5  Posters


Abstract no
Intracoronary transplantation of autologous bone-marrow cells for therapeutic angiogenesis in patients with myocardial infarction
M. Brehm, T. Zeus, M. Köstering, G. Kögler, P. Wernet, and B.E. Strauer (Düsseldorf, Germany)
77